Group One Trading’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Group One Trading's BEAM Position: Q2 2026 in Review
Group One Trading increased its Beam Therapeutics (BEAM) stake by 359% in Q2 2026, buying an estimated $349K and bringing the position to 14,776 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #3484.
Group One Trading first reported a position in BEAM in Q4 2020 and has held it in 13 quarters since. The position peaked at $5.32M in Q1 2022. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Group One Trading held 14,776 shares of Beam Therapeutics worth $507K as of Q2 2026.
- Group One Trading bought 11,560 Beam Therapeutics shares in Q2 2026, an estimated $349K.
- Beam Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3484 holding.
- Group One Trading first reported a position in Beam Therapeutics in Q4 2020 and has held it in 13 quarters since.
- Group One Trading's Beam Therapeutics position peaked at $5.32M in Q1 2022.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.